Evidence map›Paper›PMID 41224342›Full record

ReviewSaudi medical journal2025

Advances in genetic and molecular insights into thyroid disorders: Implications for diagnosis, prognosis, and personalized treatment.

Faez F Alshehri

Abstract readReview
In one paragraph

Review in Saudi medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Faez F AlshehriFrom the Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Shaqra University, Ad Dawadmi, Kingdom of Saudi Arabia.ORCID https://orcid.org/0000-0001-7991-0987

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thyroid disorders encompass a variety of autoimmune conditions such as Graves' disease, Hashimoto's thyroiditis, as well as several types of thyroid cancer. Recent advancements in next-generation sequencing methodologies have elucidated significant genetic mutations, which include

Indexed as

Precision MedicineThyroid DiseasesCTLA-4 AntigenGraves DiseaseHumansMutationPrognosisProto-Oncogene Proteins B-rafProto-Oncogene Proteins c-retThyroid NeoplasmsBRAF protein, humanCTLA-4 AntigenProto-Oncogene Proteins B-rafProto-Oncogene Proteins c-retepigeneticsgenetic insightsmolecular profilingNext-generation sequencingthyroid disorders

Identifiers

PMID41224342
PMCPMC12625667

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.